XM does not provide services to residents of the United States of America.
E
E

Equifax

News

On The Money: Should you freeze your credit? Plus, hybrid work tips

On The Money: Should you freeze your credit? Plus, hybrid work tips By Lauren Young NEW YORK, Aug 30 (Reuters) - This was originally published in the Reuters On the Money newsletter, where I share U.S. personal finance tips and insights every other week. Sign up here to receive it for free. In my most recent newsletter, I shared tips for anyone considering a move abroad during their retirement years.
E
U
E

U.S. STOCKS Li Auto, NVIDIA, CrowdStrike

BUZZ-U.S. STOCKS ON THE MOVE-Li Auto, NVIDIA, CrowdStrike Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were lower on Wednesday ahead of Nvidia's earnings, with the Nasdaq leading declines, as focus was squarely on if the recent bull market rally that was led by the AI chip firm and other tech-related shares can be sustained.
C
N
U
U
E
E
P

U.S. STOCKS Berkshire Hathaway, Super Micro Computer, Elf Beauty

BUZZ-U.S. STOCKS ON THE MOVE-Berkshire Hathaway, Super Micro Computer, Elf Beauty Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq led declines among U.S. stock indexes on Wednesday, in the run-up to AI-darling Nvidia's earnings report, with focus on if the recent bull market rally that was led by the chip firm and other tech-related shares can be sustained.
C
U
U
E
E
P

U.S. Alamo Group, Cognizant, Moderna

U.S. RESEARCH ROUNDUP-Alamo Group, Cognizant, Moderna Aug 28 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Alamo Group, Cognizant and Moderna, on Wednesday. HIGHLIGHTS * Alamo Group Inc ALG.N : D.A. Davidson raises target price to $219 from $209 * Cognizant CTSH.O : Jefferies reinstates coverage with buy rating; price target $90 * Moderna MRNA.O : HSBC raises to hold from reduce * Sonic Automotive SAH.N : CFRA rais
C
C
C
E

Equifax rises after Needham lifts PT to $350

BUZZ-Equifax rises after Needham lifts PT to $350 ** Shares of credit reporting agency Equifax EFX.N rise 1% to $306.36 ** Needham raises EFX price target to $350 from $320, which represents a 15.4% upside to stock's last close ** Brokerage says EFX stands to benefit as falling interest rates should help overall consumer lending activity ** Adds th
E

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.